Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 4
1(20.0%)
5Total
N/A(4)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02377739Not ApplicableUnknown

Non-invasive Ventilation in Patients With Interstitial Lung Disease - a Feasibility Study

Role: collaborator

NCT01987661Not ApplicableCompleted

The Effects of Airtrapping on Sleep and Breathing in Non Invasive Ventilation (NIV) in COPD

Role: collaborator

NCT01690429Not ApplicableCompleted

Arousal Analysis by Pulse Wave Amplitude in Patients With Obstructive Sleep Apnea

Role: collaborator

NCT01981915Not ApplicableCompleted

Optimum Insufflation Capacity in NMD

Role: collaborator

NCT00633711Phase 4Completed

Effects of Obstructive Sleep Apnea Treatment by Fixed CPAP and by Auto-CPAP (Somnosmart2)

Role: collaborator

All 5 trials loaded